default provider image
  • Telehealth Visits
bch logo

Marlene Maria Crespo, PsyD

Psychology (Child and Adolescent Psychology)
Early Intervention Services Oakland
877-822-4453
default provider image
default provider image
bch logo

Marlene Maria Crespo, PsyD

Psychology (Child and Adolescent Psychology)
Early Intervention Services Oakland
877-822-4453
  • Telehealth Visits

On this page

About me

Marlene Maria Crespo is a psychologist who cares for children and their families. She performs neurodevelopmental assessments and provides individual and family therapy, specializing in culturally sensitive therapy for Spanish-speaking immigrant families.

Crespo's research interests include trauma-informed treatment techniques for helping children with neurodevelopmental differences address fear; assessments as interventions, and their effects on young children and caregivers; and culturally sensitive and culturally specific approaches to care for depressed immigrant Latina patients. She has published extensively on these topics.

Crespo earned a master's degree in psychology and her doctor of psychology degree from the California Institute of Integral Studies. She is certified in infant-family and early childhood mental health and in relational therapy, which focuses on the importance of relationships to an individual's emotional well-being. She is also trained in trauma-informed assessment and interventions and in caring for patients with autism spectrum disorder and other developmental challenges.

Education

School

  • PSYD, California Institute of Integral Studies

Care Keywords

  • Services
    • Psychology (Child and Adolescent Psychology)

Locations

    Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.

    For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.

    The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.